|
|
|
||
|
|
|
Home | About | Donate/Volunteer | Contact | Jobs|  Early
Schizophrenia Screening Test |
|
|
New Harvard Schizophrenia Study Initiated - Volunteers Needed | ||||||||||
|
Researchers at Harvard Medical School are
studying a new way of treating schizophrenia. Current medications only treat
the symptoms of schizophrenia, not the cause. The treatment we are studying
may result in a more lasting improvement of symptoms by normalizing a biological
process that is thought to be irregular in this disorder. This treatment
involves taking an FDA-approved medication, in addition to the subject’s
current medication.
We are recruiting subjects who are: Compensation up to $250 will be provided to the participants. For more information, please call Andrea at 617-998-5010 The study will take place in Boston, so participants must live close
enough to come in for weekly visits. The study will last approximately
7 months (until sometime in the year 2005). For six months, study participants
will be taking the study drug (tiagabine) or placebo. For three months
the visits to our office will be weekly, then only once a month for an
additional three months. There will also be an MRI scan at the beginning
and end of the study. The study is a double-blind, placebo-controlled,
add-on design. Participants must be 18-25 years old, schizophrenic, and
on risperidone.
|
Advertisement
|
 |
